In different ways, Aβ, Tau, and αSyn each disrupt calcium signaling, suggesting that their combined effects might be responsible for the more rapid neurodegeneration seen in AD sufferers with mixed pathology [8]. The gene discussed is MAPT; the disease is Alzheimer disease.